Correction: Meropenem Use in Pediatric Oncology – Audit on Indication, Appropriateness
and Consumption Comparing Patient Derived and Pharmacy Dispensing Data
Meropenem in der Kinderonkologie – Audit zum angemessenen Einsatz sowie zum tatsächlichen
Verbrauch im Vergleich mit Apothekenlieferdaten
Autoren
Svenja Ockfen
1
Pediatric Hematology and Oncology, Children’s Hospital Medical Center, Children’s
Hospital Medical Center, Saarland University Hospital, Homburg, Germany
Leonie Egle
1
Pediatric Hematology and Oncology, Children’s Hospital Medical Center, Children’s
Hospital Medical Center, Saarland University Hospital, Homburg, Germany
Katharina Sauter
2
Paediatric Hematology and Oncology, Children's Hospital Medical Center, Homburg, Germany
Manfred Haber
3
Director Hospital Pharmacy, Saarland University Hospital, Homburg/Saar, Homburg, Germany
Sören L. Becker
4
Medical Microbiology and Hygiene, Saarland University Medical Center, Homburg, Germany
Gudrun Wagenpfeil
5
Saarland University, Campus Homburg, Institutes for Medical Biometry, Epidemiology
and Medical Informatics (IMBEI), Homburg, Germany
Norbert Graf
6
Paediatric Hematology and Oncology, Children's Hospital Medical Center, Homburg, Germany
Arne Simon
6
Paediatric Hematology and Oncology, Children's Hospital Medical Center, Homburg, Germany
